88R11675 GCB-D
 
  By: Guerra H.B. No. 3735
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the administration of opioid antagonists by a school
  nurse at public school campuses.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  The heading to Subchapter E, Chapter 38,
  Education Code, is amended to read as follows:
  SUBCHAPTER E. MAINTENANCE, [AND] ADMINISTRATION, AND DISPOSAL OF
  EPINEPHRINE AUTO-INJECTORS, [AND] ASTHMA MEDICINE, AND OPIOID
  ANTAGONISTS
         SECTION 2.  Section 38.201, Education Code, is amended by
  adding Subdivision (3-a) to read as follows:
               (3-a)  "Opioid antagonist" and "opioid-related drug
  overdose" have the meanings assigned by Section 483.101, Health and
  Safety Code.
         SECTION 3.  The heading to Section 38.208, Education Code,
  is amended to read as follows:
         Sec. 38.208.  MAINTENANCE, [AND] ADMINISTRATION, AND
  DISPOSAL OF EPINEPHRINE AUTO-INJECTORS, [AND] ASTHMA MEDICINE, AND
  OPIOID ANTAGONISTS.
         SECTION 4.  Section 38.208, Education Code, is amended by
  adding Subsections (a-2) and (c-1) and amending Subsections (c) and
  (e) to read as follows:
         (a-2)  Each school district and open-enrollment charter
  school shall adopt and implement a policy authorizing a school
  nurse to maintain, administer, and dispose of an opioid antagonist
  at each campus of the district or school.
         (c)  The executive commissioner of the Health and Human
  Services Commission, in consultation with the commissioner of
  education, and with advice from the advisory committee as
  appropriate, shall adopt rules regarding:
               (1)  the maintenance, administration, and disposal of
  an epinephrine auto-injector at a school campus subject to a policy
  adopted under Subsection (a);
               (2)  [and] the maintenance and administration of asthma
  medicine at a school campus subject to a policy adopted under
  Subsection (a-1); and
               (3)  the maintenance, administration, and disposal of
  an opioid antagonist at a school campus in accordance with a policy
  adopted under Subsection (a-2).
         (c-1)  The rules adopted under Subsection (c) must
  establish:
               (1)  the number of epinephrine auto-injectors
  available at each campus;
               (2)  the amount of prescription asthma medicine
  available at each campus;
               (3)  the amount and type of opioid antagonists
  available at each campus;
               (4)  the process for a [each] school district,
  open-enrollment charter school, and private school, as applicable,
  to check the inventory of epinephrine auto-injectors, [and] asthma
  medicine, and opioid antagonists at regular intervals for
  expiration and replacement; and
               (5) [(4)]  the amount of training required for school
  personnel and school volunteers to administer an epinephrine
  auto-injector.
         (e)  The supply of epinephrine auto-injectors at each campus
  must be stored in a secure location and be easily accessible to
  school personnel and school volunteers authorized and trained to
  administer an epinephrine auto-injector.  The supply of asthma
  medicine and opioid antagonists at each campus must be stored in a
  secure location and be easily accessible to the school nurse.
         SECTION 5.  Section 38.209, Education Code, is amended to
  read as follows:
         Sec. 38.209.  REPORT ON ADMINISTERING EPINEPHRINE
  AUTO-INJECTOR OR OPIOID ANTAGONIST.  (a) Not later than the 10th
  business day after the date a school personnel member or school
  volunteer administers an epinephrine auto-injector in accordance
  with a policy adopted under Section 38.208(a), or a school nurse
  administers an opioid antagonist under Section 38.208(a-2), the
  school shall report the information required under Subsection (b)
  to:
               (1)  the school district, the charter holder if the
  school is an open-enrollment charter school, or the governing body
  of the school if the school is a private school, as applicable;
               (2)  the physician or other person who prescribed the
  epinephrine auto-injector or opioid antagonist; and
               (3)  the commissioner of state health services.
         (b)  The report required under this section must include the
  following information:
               (1)  the age of the person who received the
  administration of the epinephrine auto-injector or opioid
  antagonist;
               (2)  whether the person who received the administration
  of the epinephrine auto-injector or opioid antagonist was a
  student, a school personnel member or school volunteer, or a
  visitor, as applicable;
               (3)  the physical location where the epinephrine
  auto-injector or opioid antagonist was administered;
               (4)  the number of doses of epinephrine auto-injector
  or opioid antagonist administered;
               (5)  the title of the person who administered the
  epinephrine auto-injector or opioid antagonist; and
               (6)  any other information required by the commissioner
  of education.
         SECTION 6.  The heading to Section 38.211, Education Code,
  is amended to read as follows:
         Sec. 38.211.  PRESCRIPTION OF EPINEPHRINE AUTO-INJECTORS,
  [AND] ASTHMA MEDICINE, AND OPIOID ANTAGONISTS.
         SECTION 7.  Sections 38.211(a), (b), (c), (e), and (f),
  Education Code, are amended to read as follows:
         (a)  A physician or person who has been delegated
  prescriptive authority under Chapter 157, Occupations Code, may
  prescribe:
               (1)  epinephrine auto-injectors or asthma medicine in
  the name of a school district, open-enrollment charter school, or
  private school; or
               (2)  opioid antagonists in the name of a school
  district or open-enrollment charter school.
         (b)  A physician or other person who prescribes epinephrine
  auto-injectors, [or] asthma medicine, or opioid antagonists under
  Subsection (a) shall provide the school district, open-enrollment
  charter school, or private school with a standing order for the
  administration of, as applicable:
               (1)  an epinephrine auto-injector to a person
  reasonably believed to be experiencing anaphylaxis; [or]
               (2)  asthma medicine to a person reasonably believed to
  be experiencing a symptom of asthma and who has provided written
  notification and permission as required by Section 38.208(b-1); or
               (3)  an opioid antagonist to a person reasonably
  believed to be experiencing an opioid-related drug overdose.
         (c)  The standing order under Subsection (b) is not required
  to be patient-specific, and the epinephrine auto-injector, [or]
  asthma medicine, or opioid antagonist may be administered to a
  person without a previously established physician-patient
  relationship.
         (e)  An order issued under this section must contain:
               (1)  the name and signature of the prescribing
  physician or other person;
               (2)  the name of the school district, open-enrollment
  charter school, or private school to which the order is issued;
               (3)  the quantity of epinephrine auto-injectors, [or]
  asthma medicine, or opioid antagonists to be obtained and
  maintained under the order; and
               (4)  the date of issue.
         (f)  A pharmacist may dispense, without requiring the name or
  any other identifying information relating to the user:
               (1)  an epinephrine auto-injector or asthma medicine to
  a school district, open-enrollment charter school, or private
  school; or
               (2)  an opioid antagonist to a school district or
  open-enrollment charter school [without requiring the name or any
  other identifying information relating to the user].
         SECTION 8.  Section 38.215(a), Education Code, is amended to
  read as follows:
         (a)  A person who in good faith takes, or fails to take, any
  action under this subchapter is immune from civil or criminal
  liability or disciplinary action resulting from that action or
  failure to act, including:
               (1)  issuing an order for epinephrine auto-injectors,
  [or] asthma medicine, or opioid antagonists;
               (2)  supervising or delegating the administration of an
  epinephrine auto-injector or asthma medicine;
               (3)  possessing, maintaining, storing, or disposing of
  an epinephrine auto-injector, [or] asthma medicine, or opioid
  antagonist;
               (4)  prescribing an epinephrine auto-injector, [or]
  asthma medicine, or opioid antagonist;
               (5)  dispensing:
                     (A)  an epinephrine auto-injector or opioid
  antagonist; or
                     (B)  asthma medicine, provided that permission
  has been granted as provided by Section 38.208(b-1);
               (6)  administering, or assisting in administering:
                     (A)  [,] an epinephrine auto-injector or opioid
  antagonist; or
                     (B)  asthma medicine, provided that permission
  has been granted as provided by Section 38.208(b-1);
               (7)  providing, or assisting in providing, training,
  consultation, or advice in the development, adoption, or
  implementation of policies, guidelines, rules, or plans; or
               (8)  undertaking any other act permitted or required
  under this subchapter.
         SECTION 9.  This Act applies beginning with the 2023-2024
  school year.
         SECTION 10.  This Act takes effect immediately if it
  receives a vote of two-thirds of all the members elected to each
  house, as provided by Section 39, Article III, Texas Constitution.  
  If this Act does not receive the vote necessary for immediate
  effect, this Act takes effect September 1, 2023.